A clinical ly relevant but not statistically significant reduction in triglycerides was found .
No impact on HDL-C levels was found .
Patients ' adherence to pharmacotherapeutic regimens and quality of life were considered possibly not sensitive and possibly sensitive to pharmacist interventions , respectively .
Total cholesterol is sensitive to pharmacist interventions , while LDL-C and triglyceride levels are possibly sensitive to those interventions .
BACKGROUND Hyperlipidemia increases the risk of cardiovascular diseases , and control is pivotal for preventing disease complications .
Multidisciplinary interventions , including those performed by pharmacists , are important for improving patients ' outcomes .
OBJECTIVE To quantify the impact of pharmacist interventions in enhancing patients ' outcomes .
Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus).
STUDY OBJECTIVE To determine the effect of a community pharmacist intervention in patients at high risk for coronary heart disease on low-density lipoprotein cholesterol ( LDL ) levels 1 year after completion of the Second Study of Cardiovascular Risk Intervention by Pharmacists ( SCRIP- plus ) . METHODS Patients who completed the original study were invited to make a single return visit to their community pharmacy so that the pharmacist could measure their fasting LDL level using a point-of-care device . The primary outcome was change in LDL level from the 6-month ( final ) visit to the extended follow-up evaluation . RESULTS Of the 359 patients who completed the original 6-month visit , data were collected for 162 ( 45 % ) patients . The mean + /- SD LDL level at completion of the original study was 107.9 + /- 33.6 mg/dl ( 2.79 + /- 0.96 mmol/L ) ( an increase of 2.7 mg/dl [ 0.07 mmol/L ] , 95 % confidence interval -19.3 - 7.3 [ -0.5 - 0.19 ] ) . Sixty-one ( 38 % ) patients were at the target LDL level ( < 96.7 mg/dl [ < 2.50 mmol/L ] ) . CONCLUSION The LDL reduction was maintained 1 year after completion of the extended follow-up . Since most patients were still not at the target LDL level , this finding suggests that continuing intervention is necessary to help patients reach this target
A clinical ly relevant but not statistically significant reduction in triglycerides was found .
No impact on HDL-C levels was found .
Patients ' adherence to pharmacotherapeutic regimens and quality of life were considered possibly not sensitive and possibly sensitive to pharmacist interventions , respectively .
Total cholesterol is sensitive to pharmacist interventions , while LDL-C and triglyceride levels are possibly sensitive to those interventions .
BACKGROUND Hyperlipidemia increases the risk of cardiovascular diseases , and control is pivotal for preventing disease complications .
Multidisciplinary interventions , including those performed by pharmacists , are important for improving patients ' outcomes .
OBJECTIVE To quantify the impact of pharmacist interventions in enhancing patients ' outcomes .